Abstract
Human umbilical cord blood (hUCB) is a primitive source of stem cells and is being banked worldwide for the purpose of future clinical use. Lineage negative (Lin-ve) stem cells are one of the primitive populations in hUCB which are capable of self-renewal and differentiation into multiple lineages. These cells have not been adequately investigated for their stem cell characteristics. We have analyzed the immunophenotypic expression of CD45, CD34 and CD117 markers on three different cell populations in hUCB viz., mononucleated cells (MNCs), Lineage positive (Lin+ve) and Lin-ve cells. The CD34 and CD117 expression was found to be 60 fold more in the Lin-ve population as compared to MNCs and Lin+ve cells. This expression was further enhanced in CD45+Lin-ve fraction. The CD34+ and CD117+ Lin-ve cells showed 99% positivity for CD45. Our data suggest that CD34+ CD117+ Lin-ve cells are reasonably enriched stem cell population in hUCB which can be clinically used for transplantation and other therapeutic purposes.
Keywords: CD117, CD34, haematopoietic, lineage, stem cell, umbilical cord blood.
Current Neurovascular Research
Title:An Enriched Population of CD45, CD34 and CD117 Stem Cells in Human Umbilical Cord Blood for Potential Therapeutic Regenerative Strategies
Volume: 11 Issue: 4
Author(s): Avijit Banik, Sudesh Prabhakar, Jasvinder Kalra and Akshay Anand
Affiliation:
Keywords: CD117, CD34, haematopoietic, lineage, stem cell, umbilical cord blood.
Abstract: Human umbilical cord blood (hUCB) is a primitive source of stem cells and is being banked worldwide for the purpose of future clinical use. Lineage negative (Lin-ve) stem cells are one of the primitive populations in hUCB which are capable of self-renewal and differentiation into multiple lineages. These cells have not been adequately investigated for their stem cell characteristics. We have analyzed the immunophenotypic expression of CD45, CD34 and CD117 markers on three different cell populations in hUCB viz., mononucleated cells (MNCs), Lineage positive (Lin+ve) and Lin-ve cells. The CD34 and CD117 expression was found to be 60 fold more in the Lin-ve population as compared to MNCs and Lin+ve cells. This expression was further enhanced in CD45+Lin-ve fraction. The CD34+ and CD117+ Lin-ve cells showed 99% positivity for CD45. Our data suggest that CD34+ CD117+ Lin-ve cells are reasonably enriched stem cell population in hUCB which can be clinically used for transplantation and other therapeutic purposes.
Export Options
About this article
Cite this article as:
Banik Avijit, Prabhakar Sudesh, Kalra Jasvinder and Anand Akshay, An Enriched Population of CD45, CD34 and CD117 Stem Cells in Human Umbilical Cord Blood for Potential Therapeutic Regenerative Strategies, Current Neurovascular Research 2014; 11 (4) . https://dx.doi.org/10.2174/1567202611666140902144836
DOI https://dx.doi.org/10.2174/1567202611666140902144836 |
Print ISSN 1567-2026 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5739 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pathogenesis, Experimental Models and Contemporary Pharmacotherapy of Irritable Bowel Syndrome: Story About the Brain-Gut Axis
Current Neuropharmacology Anti-Inflammatory Therapy for Alzheimer’s Disease from Epidemiological Fact to New Mechanisms of Action
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry The Atypical Cannabinoid O-1602: Targets, Actions, and the Central Nervous System
Central Nervous System Agents in Medicinal Chemistry Research on the Possibility of Overcoming Traumatic Paraplegia and Its First Clinical Results
Current Pharmaceutical Design Neuropeptide/Receptor Expression and Plasticity in Micturition Pathways
Current Pharmaceutical Design BACE1 Structure and Function in Health and Alzheimers Disease
Current Alzheimer Research VIP in Neurological Diseases: More Than A Neuropeptide
Endocrine, Metabolic & Immune Disorders - Drug Targets Bone Seeking Radiopharmaceuticals for Palliation of Pain in Cancer Patients with Osseous Metastases
Anti-Cancer Agents in Medicinal Chemistry Nanotechnology in Neuroscience and its Perspective as Gene Carrier
Current Topics in Medicinal Chemistry Role of PGE2 in Blood Pressure Regulation
Current Hypertension Reviews Recent Patents on Cell-based Approaches for Intervertebral Disc Regeneration
Recent Patents on Biomedical Engineering (Discontinued) The Role of Venous Abnormalities in Neurological Disease
Reviews on Recent Clinical Trials Recent Progress Toward Hydrogen Medicine: Potential of Molecular Hydrogen for Preventive and Therapeutic Applications
Current Pharmaceutical Design Free Area of the Spinal Canal and Torg’s Ratio in Acute Cervical Trauma and Degenerative Disease: MANCOVA and Correlational Analyses
Current Medical Imaging Patent Selections
Recent Patents on Medical Imaging The Use of Stem Cells for the Treatment of Spinal Surgical Conditions.
Current Stem Cell Research & Therapy Modified Polysaccharides as Versatile Materials in Controlled Delivery of Antidegenerative Agents
Current Pharmaceutical Design New Insights into the Mechanism of Action of Aspirin in the Prevention of Colorectal Neoplasia
Current Pharmaceutical Design Mitochondria-Targeted Drugs
Current Molecular Pharmacology Overactive Bladder Syndrome, Detrusor Overactivity and the Botulinum Toxin
Reviews on Recent Clinical Trials